1646112251
JCO Precision Oncology Conversations

Advertise on podcast: JCO Precision Oncology Conversations

Rating
★★★★★
5
from
5 reviews
This podcast has
82 episodes
Language
English
Date created
2022/09/20
Latest episode
2026/11/03
Average duration
19 min.
Release period
12 days

Description

JCO Precision Oncology Conversations is a monthly podcast featuring conversations with authors of clinically relevant and significant articles published in the JCO Precision Oncology journal. JCO Precision Oncology Conversations is hosted by the journal's social media editor, Dr. Abdul Rafeh Naqash.

Unlock JCO Precision Oncology Conversations podcast Email contact info,
Listeners & Audience details

Email contact information

Direct podcast contact details

Listeners

Audience numbers & engagement insights

Audience details

Podcast Insights

Podcast episodes

Check latest episodes from JCO Precision Oncology Conversations podcast


Pancreatic Imaging Findings in BRCA1/BRCA2/ATM/PALB2 Carriers
2026/11/03
JCO PO author Dr. Bryson Katona shares insights into the JCO PO article, "Longitudinal Pancreatic Imaging Findings in BRCA1, BRCA2, ATM, and PALB2 Heterozygotes Undergoing Pancreatic Cancer Surveillance: A Prospective PRECEDE Consortium Study." Host Dr. Rafeh Naqash and Dr. Katona discuss how, in this largest reported cohort of BRCA1, BRCA2, ATM, and PALB2 heterozygotes undergoing PC surveillance imaging, benign/low-risk pancreatic imaging findings were common and stable on short-term follow-up, providing important data for counseling these HRIs. LINK TO FULL TRANSCRIPT
Assessment of 2022 CMMRD Diagnostic Criteria
2026/11/02
JCO PO author Melyssa Aronson shares insights into the JCO PO article, "Assessment of the 2022 Constitutional Mismatch Repair Deficiency syndrome (CMMRD) diagnostic criteria using the International Replication Repair Deficiency Consortium (IRRDC)." Host Dr. Rafeh Naqash and Professor Aronson discuss how refinement of CMMRD diagnostic criteria may address atypical presentation and discordant functional results. LINK TO FULL TRANSCRIPT
EPCAM Deletion Architecture Defines Distinct Cancer Phenotype
2026/11/02
JCO PO authors Dr. Kristin Kohler, Heather Hampel, and Dr. Michael Hall share insights into the JCO PO article, "Redefining the EPCAM Phenotype: Deletion Architecture Determines Lynch Syndrome Cancer Risk." Host Dr. Rafeh Naqash and guests discuss how the findings provide new insights into the molecular and clinical heterogeneity of germline deletions involving EPCAM. LINK TO FULL TRANSCRIPT
JCO PO Article Insights: Tumor-informed ctDNA in Early Triple Negative Breast Cancer
2026/10/28
In this JCO PO Article Insights episode, host Dr. Carolyn Lineen summarizes the article, "Evaluation of a Tumor-Informed Molecular Residual Disease Assay in Early Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy, With or Without Atezolizumab" by Balic and colleagues. LINK TO FULL TRANSCRIPT
EMR-Based Nudge Improves Molecular Testing in Early-Stage NSCLC
2026/10/21
JCO PO authors Dr. Melina Marmarelis and Dr. Charu Aggarwal at University of Pennsylvania share insights into the JCO PO article, "EMBER-Lung: Electronic Medical Record Boosting Molecular Testing in Early-Stage NSCLC." Host Dr. Rafeh Naqash and guests discuss how embedding behavioral nudges within clinical workflows can help overcome barriers to biomarker testing in early-stage NSCLC. LINK TO FULL TRANSCRIPT
JCO PO Article Insights: CTCs as Biomarkers in GBM
2026/09/30
In this episode of JCO Precision Oncology Article Insights, host Jiasen He summarizes the article, "Beyond the Brain: Circulating Tumor Cells as a Tool for Diagnosis and Monitoring," by Lessi and colleagues. LINK TO FULL TRANSCRIPT
A Decade of Data: JCO PO and the TAPUR Study
2026/09/16
JCO PO Editor-in-Chief Emeritus Dr. James Ford and Founding PI, ASCO TAPUR Study, Dr. Richard Schilsky discuss the 10-year anniversary of the Targeted Agent and Profiling Utilization Registry (TAPUR)™ Study and its relationship with the journal. Host Dr. Rafeh Naqash and guests discuss the inception/history of the TAPUR study, its future, and advances in precision medicine over the past decade. LINK TO FULL TRANSCRIPT
JCO PO Article Insights: Breast Neuroendocrine Carcinoma Beyond Histology
2026/08/26
In this JCO PO Article Insights episode, host Carolyn Lineen summarizes the article, "Breast Neuroendocrine Carcinoma: Molecular Insights Beyond Histology" by Schwartz and colleagues. LINK TO FULL TRANSCRIPT
cfDNA Epigenetics for Toxicity Monitoring
2026/08/19
JCO PO authors Dr. James Hadfield, Dr. Grace Yiqing Zhao, and Dr. Julia Elvin at AstraZeneca share insights into the JCO PO article, "Beyond Circulating Tumor DNA for Efficacy: Can We Use Cell-Free DNA to Detect and Monitor Toxicity Signals?" Host Dr. Rafeh Naqash and guests discuss emerging evidence that cfDNA methylation profiling provides sensitive, specific signals of tissue injury across multiple organs and clinical contexts. LINK TO FULL TRANSCRIPT
JCO PO Article Insights: Clinical ctDNA Testing in Advanced Pediatric Solid Tumors
2026/07/29
In this episode of JCO PO: Article Insights, host Jiasen He summarizes the article, "Clinical Liquid Biopsy Testing for Detection of Actionable Genomic Alterations in Children and Young Adults With Advanced Solid Tumors on the GAIN Study," by Roberts and colleagues. LINK TO FULL TRANSCRIPT
ALK+ Squamous and Adenosquamous NSCLC
2026/07/15
JCO PO author Dr. Emily Miao at Mass General Brigham Cancer Institute shares insights into the JCO PO article, "Clinicogenomic Characteristics and Treatment Outcomes of Patients With Advanced ALK-Rearranged Squamous and Adenosquamous Non–Small Cell Lung Cancers." Host Dr. Rafeh Naqash and Dr. Miao discuss the clinicogenomic characteristics and treatment outcomes of patients with ALK+ squamous and adenosquamous lung cancers and how these outcomes compare to those of patients with ALK+ adenocarcinoma treated with first-line alectinib. LINK TO FULL TRANSCRIPT
JCO PO Article Insights: Genomics of MTAP Loss and Co-Alteration Landscape
2026/06/24
In this JCO PO Article Insights episode, host Carolyn Lineen summarizes the article, "Genomics of MTAP Loss in >500,000 Solid Tumor Specimens Profiled Using Comprehensive Genomic Profiling Platforms" by Dean C. Pavlick and colleagues. LINK TO FULL TRANSCRIPT
Immune Checkpoint Blockade in dMMR/MSI-H Advanced UTUC
2026/06/17
JCO PO authors Dr. Matthew Campbell and Dr. Mohammad Moussa at The University of Texas MD Anderson Cancer Center and Baylor College of Medicine, Houston, Texas, share insights into their article, "Efficacy of Immune Checkpoint Blockade in Advanced Upper Tract Urothelial Cancer With DNA Mismatch Repair Deficiency or Microsatellite Instability." Host Dr. Rafeh Naqash and Drs. Campbell and Moussa discuss how the study findings suggest that dMMR/MSI-H may serve as a biomarker of sensitivity to single-agent ICIs in advanced UTUC. LINK TO FULL TRANSCRIPT
JCO PO Article Insights: Dynamic Monitoring of Anti-EGFR Resistance in Metastatic Colorectal Cancer
2026/05/27
In this JCO PO Article Insights episode, host Jordan Goldstein summarizes the article, "EXONERATE-TRaCE: A Liquid Biopsy for Tracking Response to Anti–Epidermal Growth Factor Receptor–Based Therapy in Metastatic Colorectal Cancer" byTakahashi,  et al. LINK TO FULL TRANSCRIPT
Phase II Study of Seribantumab in Tumors Harboring NRG1 Fusions
2026/05/20
JCO PO author Dr. Tejas Patil at University of Colorado Cancer Center shares insights into the JCO PO article, "CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (NRG1) Fusions". Host Dr. Rafeh Naqash and Dr. Patil discuss the anti-tumor activity and safety data of seribantumab from the CRESTONE study (NCT04383210). LINK TO FULL TRANSCRIPT

Podcast reviews

Read JCO Precision Oncology Conversations podcast reviews


5 out of 5
5 reviews
★★★★★
lexigreen361 2026/02/24
Great show!
Fantastic show that helps a busy resident digest important articles from JCO
check all reviews on apple podcasts

Podcast sponsorship advertising

Start advertising on JCO Precision Oncology Conversations relevant audience podcasts


What do you want to promote?